Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Mesoblast, Ltd.
Universität des Saarlandes
Universität des Saarlandes
Universität des Saarlandes
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Polish Lymphoma Research Group
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
AIDS Malignancy Consortium
National Cancer Institute (NCI)
Children's Oncology Group
Centre Henri Becquerel
National Cancer Institute (NCI)
University of California, San Francisco
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC
Northwestern University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center